What antibiotics are recommended for treating adult community‑acquired pneumonia, including outpatient, inpatient, and drug‑resistant cases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Antibiotic Treatment for Adult Community-Acquired Pneumonia

For outpatient CAP without comorbidities, use amoxicillin plus a macrolide (azithromycin or clarithromycin), or alternatively a respiratory fluoroquinolone (levofloxacin or moxifloxacin) as monotherapy. 1

Outpatient Treatment Algorithm

Previously Healthy, No Recent Antibiotics

  • Aminopenicillin (amoxicillin 500-1000 mg every 8 hours) PLUS macrolide (azithromycin 500 mg daily for 3 days OR clarithromycin 250-500 mg twice daily) 1
  • Alternative: Respiratory fluoroquinolone monotherapy (levofloxacin 750 mg daily OR moxifloxacin 400 mg daily) 2
  • Alternative: Doxycycline 100 mg twice daily 1

With Comorbidities or Recent Antibiotic Use (within 90 days)

  • Respiratory fluoroquinolone (levofloxacin or moxifloxacin) 2
  • OR Beta-lactam/beta-lactamase inhibitor PLUS macrolide (amoxicillin-clavulanate 1 g every 8 hours plus azithromycin or clarithromycin) 1

Treatment duration: 3-5 days minimum for outpatients who achieve clinical stability, rather than the traditional ≥5 days 3, 4

Hospitalized Non-ICU Patients

Use either a beta-lactam PLUS macrolide combination OR respiratory fluoroquinolone monotherapy. 2

Standard Regimen (No MRSA/Pseudomonas Risk)

  • Ceftriaxone 1-2 g daily OR cefotaxime 1-2 g every 8 hours PLUS azithromycin 500 mg daily 2, 5
  • OR Ampicillin-sulbactam 1.5-3 g every 6 hours PLUS macrolide 5
  • OR Respiratory fluoroquinolone alone (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) 1, 2

With MRSA Risk Factors

Add MRSA coverage if: IV antibiotics within 90 days, MRSA prevalence >20% in unit, or high mortality risk 6, 5

  • Add vancomycin 15 mg/kg every 8-12 hours (target trough 15-20 mg/mL) OR linezolid 600 mg every 12 hours 6, 5
  • Obtain nasal PCR and cultures to allow de-escalation 5

Treatment duration: Generally should not exceed 8 days in responding patients; biomarkers like procalcitonin may guide shorter duration 1

Severe CAP (ICU Admission)

All severe CAP requires combination therapy with a beta-lactam PLUS either a macrolide OR fluoroquinolone. 2

Without Pseudomonas Risk

  • Ceftriaxone 1-2 g daily OR cefotaxime 1-2 g every 8 hours PLUS azithromycin 500 mg daily 2
  • OR Beta-lactam PLUS levofloxacin 750 mg daily or moxifloxacin 400 mg daily 1, 2

With Pseudomonas Risk Factors

Risk factors include: structural lung disease (bronchiectasis, cystic fibrosis), recent broad-spectrum antibiotics 2

Use antipseudomonal beta-lactam PLUS dual coverage:

  • Piperacillin-tazobactam 4.5 g every 6 hours OR cefepime 2 g every 8 hours OR meropenem 1 g every 8 hours 1, 2
  • PLUS ciprofloxacin 400 mg every 8 hours OR levofloxacin 750 mg daily 1, 2
  • OR PLUS aminoglycoside (gentamicin 5-7 mg/kg daily, tobramycin 5-7 mg/kg daily, or amikacin 15-20 mg/kg daily) PLUS azithromycin 2

With MRSA Risk

  • Add vancomycin 15 mg/kg every 8-12 hours (target trough 15-20 mg/mL) OR linezolid 600 mg IV every 12 hours 2, 5

Treatment duration: Minimum 5 days for severe CAP 3, 4

Hospital-Acquired Pneumonia (HAP)

Low Mortality Risk, No MRSA Factors

Choose ONE agent with MSSA coverage 6:

  • Piperacillin-tazobactam 4.5 g IV every 6 hours
  • Cefepime 2 g IV every 8 hours
  • Levofloxacin 750 mg IV daily
  • Imipenem 500 mg IV every 6 hours
  • Meropenem 1 g IV every 8 hours

High Mortality Risk OR Recent IV Antibiotics

Use TWO agents (avoid two beta-lactams) PLUS MRSA coverage 6:

  • Choose TWO from above list (one beta-lactam plus fluoroquinolone OR aminoglycoside)
  • PLUS vancomycin 15 mg/kg every 8-12 hours OR linezolid 600 mg every 12 hours 6

Critical Pitfalls to Avoid

  1. Macrolide monotherapy is inadequate for hospitalized patients due to increasing pneumococcal resistance 2

  2. Do NOT delay antibiotics: Initiate immediately upon diagnosis, especially in septic patients 1

  3. Penicillin allergy: If severe, use respiratory fluoroquinolone plus aztreonam for severe CAP; avoid beta-lactams entirely 2

  4. Switch to oral therapy when hemodynamically stable, clinically improving, and able to tolerate oral intake—typically within first 3 days. No need for prolonged IV observation 2

  5. De-escalate based on cultures: Once pathogen identified, narrow to pathogen-directed therapy 2

  6. Regional resistance patterns matter: In areas with >25% high-level macrolide-resistant S. pneumoniae, avoid macrolide monotherapy even in outpatients 2

  7. Atypical pathogen coverage: Macrolides, doxycycline, or fluoroquinolones cover Legionella, Mycoplasma, and Chlamydophila; beta-lactams alone do not 1

References

3
Research

2025 guideline updates for community-acquired pneumonia diagnosis and management.

The American journal of emergency medicine, 2026

Related Questions

What is the recommended outpatient treatment for low‑risk community‑acquired pneumonia in an otherwise healthy patient under 65 years old with no comorbidities, no recent antibiotic use, and no recent travel or drug‑resistant exposure?
What is the recommended outpatient management for a healthy adult ≤65 years old with community-acquired pneumonia and no comorbidities?
What antibiotic regimen should be used for an otherwise healthy adult with community-acquired pneumonia, including options for penicillin allergy, recent antibiotic use, chronic lung disease, and renal impairment?
What inpatient antibiotic regimen is recommended for an adult patient with community‑acquired pneumonia who failed outpatient treatment with amoxicillin‑clavulanate (Augmentin), azithromycin, and ceftriaxone (Rocephin) and now requires hospital admission?
What is the appropriate outpatient antibiotic regimen for an adult with community‑acquired pneumonia, including recommendations for healthy patients and those with comorbidities or recent antibiotic exposure?
What are the symptoms of a thoracic aortic dissection?
What are the possible causes of a transferrin saturation of 10%, ferritin level of 250 µg/L, normal C‑reactive protein, and hemoglobin of 15 g/dL?
What does a serum gamma‑glutamyl transferase (GGT) level of 41 U/L indicate?
What is the clinical significance and recommended management of ST elevation in the aVR lead?
What are the diagnostic workup and treatment options for a patient presenting with sudden weakness of the lower extremities?
In an elderly, underweight patient who does not consume alcohol and has recent delirium, what is the clinical significance of a serum gamma‑glutamyltransferase of 41 U/L and what work‑up should be pursued?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.